Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$19.88 USD

19.88
217,606

+0.18 (0.91%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $19.88 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (146 out of 251)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sejuti Banerjea headshot

Brokers Just Love These 5 Stocks

by Sejuti Banerjea

Here are 5 stocks you should buy right now.

Newell Loses 22% YTD: Can Its Transformation Plan Aid Stock?

by Zacks Equity Research

Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appears encouraging.

4 Fitness Stocks to Buy This Summer

by Zacks Equity Research

Growing consumer preference for a healthy lifestyle could boost America's fitness industry.

Avon (AVP) Rallies 42% in 3 Months: What's Aiding the Stock?

by Zacks Equity Research

Avon (AVP) progresses well on its 'Open Up Avon' strategy. Also, the company remains committed to attain its long-term financial targets.

Consumer Beauty Hurts Coty: Can Efforts Revive Lost Sheen?

by Zacks Equity Research

Coty's (COTY) Consumer Beauty unit struggles against soft organic sales. Also, supply-chain disruptions are a drag.

Newell to Sell USPC Business, Transformation Plan on Track

by Zacks Equity Research

Newell (NWL) agrees to divest the United States Playing Card Company to Cartamundi Group. This move is in sync with the company's Transformation Plan.

Smucker's (SJM) Q4 Earnings Top Estimates, Buyout Boosts Sales

by Zacks Equity Research

Smucker's (SJM) top and bottom lines improve during Q4. Performance gains from the Ainsworth buyout, while the divestiture of the U.S. baking business is a drag.

Will Archer Daniels' Strategic Growth Efforts Drive Stock?

by Zacks Equity Research

Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.

3 Reasons Why Medifast (MED) Is a Great Growth Stock

by Zacks Equity Research

Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike

by Zacks Equity Research

Clorox (CLX) enhances shareholder returns by a 10% hike in its quarterly dividend.

Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Is (MED) Outperforming Other Consumer Staples Stocks This Year?

Swarup Gupta headshot

6 Defensive Stocks to Combat Market Turbulence

by Swarup Gupta

With the trade war likely to weigh on the global economy, defensive stocks are a prudent choice for investors.

Flowers Foods (FLO) Stock Rises on Q1 Earnings & Sales Beat

by Zacks Equity Research

Flowers Foods (FLO) Q1 results gain on solid pricing, improvements at DKB, Nature's Own and Wonder brands and contributions from Canyon Bakehouse.

General Mills (GIS) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

General Mills (GIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Boston Beer Fortifies Craft Footprint with Dogfish Head Merger

by Zacks Equity Research

Boston Beer (SAM) enters into a merger agreement with Dogfish Head Brewery in a cash and stock deal worth about $300 million.

Top Ranked Growth Stocks to Buy for May 9th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, May 9th.

Medifast (MED) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Medifast (MED) delivered earnings and revenue surprises of 11.84% and 9.35%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Medifast's (MED) Q1 Earnings to Gain From OPTAVIA Brands

by Zacks Equity Research

Sturdy growth in the OPTAVIA banner is likely to boost Medifast's (MED) Q1 results. However, rising freight and SG&A expenses are concerns.

Helen of Troy (HELE) Q4 Earnings Beat Estimates, Sales Down

by Zacks Equity Research

Helen of Troy's (HELE) Q4 performance benefits from improved margins as well as strength in the Housewares businesses. However, sluggish Health & Home unit disappoints.

Archer Daniels (ADM) Q1 Earnings Miss Estimates, Down Y/Y

by Zacks Equity Research

Archer Daniels (ADM) reports dismal first-quarter 2019 earnings due to adverse winter weather conditions in North America, which hurt the company's operations.

Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Is (MED) Outperforming Other Consumer Staples Stocks This Year?

Top Ranked Growth Stocks to Buy for April 26th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 26th.

Buyouts & Lower Costs Drive Hershey's (HSY) Q1 Earnings

by Zacks Equity Research

Hershey's (HSY) Q1 earnings and sales increase year over year and also beat the Zacks Consensus Estimate.

Altria's (MO) Q1 Earnings Miss Estimates, High Interests Hurt

by Zacks Equity Research

Altria's (MO) Q1 performance hurt by high interest expenses as well as lower revenues in the smokeable segment.

Medifast (MED) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.